Pinned Tweet
The difficulty as a trader is when and how to adjust risk. I could have blown up all the profits of the year, but since around Oct I took out the high lev bet. Reduced since and still up on the year more than +350%. I was up more than +500%.
64
A lot of great technical buying signals with fast rising EMAs in this biopharma company, Insmed—if you care to look at the healthcare space while AI and chip stocks look outright ugly. $INSM
1
123
JCFD trades retweeted
A lot of great technical buying signals with fast rising EMAs in this biopharma company, Insmed—if you care to look at the healthcare space while AI and chip stocks look outright ugly. $INSM
JCFD trades retweeted
$XE today reported third quarter results that reflect meaningful progress across licensing, our project pipeline, and fuel technology. Read more: hubs.la/Q04F5qQY0
$XE ripping on earnings - execution is outstanding - they proved it! The future is nuklear.
97
$NBIS - last time we were ranging for about 6 months b4 we broke out... I will be back at nebius in a few months, not yet.
137
$TEM
Probably one of the best weekly setups in the market right now
Massive IPO base
Strong theme + catalyst
Long and looking to add through $89
52
JCFD trades retweeted
I actually think this is finally the run for $TEM
Out of this chop we’ve been in basically since IPO
>Fundamentally it’s finally flipping profitable
> They’re only becoming more attractive to companies that want to use AI to create drugs faster
> They can grow at this rate for a decade if not DECADES in my opinion
> They still haven’t expanded out of cancer nearly as much as I expect
Lot of levers to pull
Lot of accumulation has already happened

















